• Gilead Sciences (GILD.US) rose over 5% in premarket trading
• Boeing (BA.US) stock surges higher
US indices opened higher on Monday, extending last week's sharp gains after a surprising NFP report which strengthened investors opinion that the U.S. economy has weathered the worst of the economic fallout from the coronavirus. Airlines, retailers and cruise lines are among the best performers. The benchmark S&P 500 (SPX) and the Dow (DJI) are now 5.7% and 8.3% away from their respective closing highs, after surging more than 45% from their pandemic lows hit on March 23, as majority of the companies resumed operations following weeks of pandemic related shutdowns. Meanwhile, protests over police brutality and the death of George Floyd continued all over the country for the 13th straight day. All eyes this week will be turned to the Federal Reserve's two-day policy meeting, ending on Wednesday, during which recent report from the labor market is expected to be discussed.
S&P500 (US500) is testing local resistance at 3218.3 pts. If some positive news hits the market, the price may move towards resistance at 3400 pts. However, if the seller manages to regain control of the market, then support around 3159.7 may be at risk. Source: xStation5
Boeing (BA.US) launched todays session with a bullish price gap. Shall upbeat moods prevail local resistance at $252.53 per share may come into play. Source: xStation5
AstraZeneca (AZN.US) contacted Gilead Sciences (GILD.US) last month about a merger between the two drugmakers, according to a Bloomberg report. However according to other sources AstraZeneca is no longer interested in pursuing such a deal.
Facebook (FB.US) - CEO Mark Zuckerberg announced the company will review existing policies on content related to civil unrest and violence, following criticism over its stance of not moderating or taking down some posts related to those subjects.
US100: Wall Street's stronghold of growth❓
Daily summary: Sentiments on Wall Street stall at the end of the week🗽US Dollar gains
US100 loses 0.5% 📉Meta shares decline extends on AI CAPEX worries & Deutsche Bank remarks
AbbVie near 1-month low after earnings report 📉